Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home2/don/public_html/daily-enews-archives.php:5) in /home2/don/public_html/header08.php on line 1
OBR Daily - Our Oncology Focused E-News Service

Register for OBR daily

Warning: Missing argument 1 for showSidebarBanner(), called in /home2/don/public_html/sidebar_obrgreen.php on line 38 and defined in /home2/don/public_html/include/banners.php on line 243

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

GERN $3.70 0.4500 +13.85%
GALE $2.07 0.2100 +11.29%
FATE $4.23 0.3800 +9.87%
PGNX $6.77 0.3500 +5.45%
NLNK $35.33 1.8100 +5.40%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

ARGS $8.50 -0.4100 -4.60%
EPZM $22.49 -1.0700 -4.54%
CLVS $48.60 -2.1900 -4.31%
CPXX $1.86 -0.0800 -4.12%
GALT $4.20 -0.1500 -3.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 877 | 878 | 879 | 880 | 881 | 882 | 883 | 884 | 885 | 886 | Next > | Last >>

WHO Takes on Chronic Disease

(Washington Post) Apr 29, 2011 - The World Health Organization focused for decades on infectious diseases, but now it’s putting non-communicable diseases near the top of its agenda.
read article (free registration required) 

How Much Medical Testing Is Too Much?

(Los Angeles Times) May 2, 2011 - Recommendations for tests abound, but not all are necessary. Put some thought into what you subject yourself to and why.
read article (free registration required) 

Opinion: The Right Way to Reform Medicare

(Wall Street Journal) Apr 29, 2011 - In recent weeks, our country has continued an important conversation about our fiscal future.
read article (paid subscription required) 

Obama’s Medicare Chief Has Accidental Encounter With Reality, Learns Nothing

(Forbes/Money & Politics Blog) May 1, 2011 - Donald Berwick, the person appointed by Obama to be in charge of Medicare, has a column in the Wall Street Journal that makes a very good observation about how relative prices are falling for products bought and sold in the free market.
read article 

Life Beyond Lipitor for Pfizer Chief

(Wall Street Journal) May 2, 2011 - Since he was thrust into the job of leading Pfizer Inc. in December following the abrupt departure of predecessor Jeffrey Kindler, Chief Executive Ian Read has been on a mission: Make the world's largest drug maker leaner and meaner.
read article (paid subscription required) 

Teva to Buy Cephalon for $6.2 Billion, Topping Valeant Bid

(Bloomberg Businessweek) May 2, 2011 - Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, agreed to buy Cephalon Inc. for $6.2 billion, trumping a hostile offer from Valeant Pharmaceuticals International Inc.
read article 

Three in Running at M.D. Anderson

(Houston Chronicle) May 2, 2011- The University of Texas M.D. Anderson Cancer Center's second in command, the head of the University of New Mexico Cancer Center and a Harvard researcher are the finalists to become the Houston research hospital's new president, according to campus sources.
read article 

Health Literacy Tests Underutilized; May Improve Elderly Cancer Patients’ Care and Outcomes

(MD Anderson) Apr 29, 2011 - Low health literacy is a significant barrier to quality care, especially among elderly patients, but increased use of simple and effective health literacy assessment tests by nurses and clinicians can help improve communication and health outcomes.
read press release 

Q&A with Peoria Breast Surgeon Lynne Jalovec

(Peoria Journal Star, IL) Apr 30, 2011 - Imagine a day in the not-too-distant future when your family doctor runs genetic tests on you - specific screenings based on your family medical history.
read article 

Op-Ed: Unsafe at Any Dose

(New York Times) Apr 30, 2011 - Doctors must do more than treat cancers. We must enter the nuclear debate.
read article 

Editorial: Let's Protect Cancer Research Funds

(Houston Chronicle) May 1, 2011 - We are making unprecedented progress that is changing the way we prevent and treat cancer in this country, thanks in no small part to federal investments in cancer research.
read article 

Drug Makers Develop Medicines to Meet Asia's Needs

(BBC World News) May 2, 2011 - Three-quarters of the world's liver cancer cases in males and two-thirds in females occur in Asia.
read article 

Strides Announces U.S. FDA Approval for Its Oncology Facility in Bangalore

(Strides Arcolab Ltd.) May 2, 2011 - Onco Therapies Limited, a division of Agila today announced that it has received approval from the US FDA for its Oncology facility in Bangalore, a much awaited decision that will enable Strides to play a more significant role in the global oncology industry.
download pdf 

Zeltia Says J&J Withdraws Cancer Drug Petition

(Reuters) Apr 29, 2011 - Spanish drug company Zeltia said on Friday U.S. group Johnson & Johnson had withdrawn its petition to the Federal Drug Administration to authorise the use of Yondelis in combination with Doxil.
read article 

Complementary Treatments for Cancer: The Role Reiki And Massage Can Play in Treatment

(The Huffington Post) May 2, 2011 - Modern medicine has transformed death and dying. Whereas a "terminal" diagnosis once meant that death was more or less imminent, increasingly "terminal" illness refers to a chronic and potentially fatal disease.
read article 

Finding Molecular Targets of an HIV Drug Used in Cancer Therapy

(UC San Diego) Apr 28, 2011 - Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy.
read press release 

Fox Chase Researchers Find that Aspirin Reduces the Risk of Cancer Recurrence in Some Prostate Cancer Patients

(Fox Chase) May 1, 2011 - Some studies have shown that blood-thinning medications, such as aspirin, can reduce biochemical failure––cancer recurrence that is detected by a rising prostate-specific antigen (PSA) level––the risk of metastasis and even death in localized prostate cancer.
read press release 

Investigational Agent Shows Promise in Reducing Spread of Prostate Cancer

(Georgetown Lombardi CCC) Apr 29, 2011 - A drug developed to treat Ewing’s Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, as seen in new lab studies say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center (GUMC).
read press release 

Mayo Clinic Finds Robotic Surgery Effective for Removing Hard-to-Reach Throat Cancer

(Mayo Clinic) Apr 29, 2011 - Robotic surgery has become a mainstream tool for removing an ever-increasing variety of head and neck tumors. Now, a team of head and neck surgeons from Mayo Clinic has found robotic surgery can treat cancer in the narrow, hard-to-reach area beyond the tongue at the top of the voice box.
read press release 

Majority of Nurses Uncomfortable Talking About Sexuality with Cancer Patients

(MD Anderson) Apr 29, 2011 - Nurses and other health care providers are unprepared and uncomfortable when initiating discussions about sexuality with their patients, according to an abstract presented at the 36th Annual Congress of the Oncology Nursing Society by nurses from The University of Texas MD Anderson Cancer Center.
read press release 

Seattle Genetics Says FDA Is Reviewing Cancer Drug

(Seattle Post-Intelligencer/Associated Press) May 2, 2011 - Seattle Genetics Inc. said Monday the Food and Drug Administration is now reviewing its experimental cancer drug as a treatment for Hodgkin's disease and a type of lymphoma.
read article 

Review Casts More Doubts on a Lung Cancer Study

(New York Times) Apr 29, 2011 - A confidential review of a continuing lung cancer study involving more than 50,000 patients found that doctors could not locate 90 percent of the patients' consent forms.
read article 

Fewer Mammograms Being Done, Studies Show

(CNN Health) May 2, 2011 - The use of mammograms has dipped since a medical task force made controversial recommendations that women in their 40s may not need to get breast cancer screenings every year, according to one of three small studies to be presented Monday.
read article 

Seattle Genetics Announces FDA Accepts Brentuximab Vedotin BLAs for Filing and Grants Priority Review for Relapsed or Refractory Hodgkin Lymphoma and Systemic ALCL

(Seattle Genetics) May 2, 2011 - Seattle Genetics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for the treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL).
read press release 

Spectrum Wins Expanded Use for Drug Fusilev

(Forbes/Associated Press) Apr 30, 2011 - Spectrum Pharmaceuticals Inc. has won U.S. regulatory approval to market a drug for treating patients with advanced colorectal cancer, an expanded use for the injectable medication.
read article